Sale of 20,000 shares at $11.2474 per share.
Reporting Person McFarlane Neil F. · Officer Title President and CEO · Transaction Code S
Traded Oct 12, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001434647-26-000075 · filed 2026-10-13 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "ZEVRA THERAPEUTICS, INC. (ZVRA)." Disclosed 2026-10-13. https://desqlong.com/cards/0001434647-26-000075-2 (retrieved 2026-10-14).